Literature DB >> 24034142

Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation.

P Perrin1, S Caillard, R M Javier, L Braun, F Heibel, C Borni-Duval, C Muller, J Olagne, B Moulin.   

Abstract

The risk of fractures after kidney transplantation is high. Hyperparathyroidism frequently persists after successful kidney transplantation and contributes to bone loss, but its impact on fracture has not been demonstrated. This longitudinal study was designed to evaluate hyperparathyroidism and its associations with mineral disorders and fractures in the 5 posttransplant years. We retrospectively analyzed 143 consecutive patients who underwent kidney transplantation between August 2004 and April 2006. The biochemical parameters were determined at transplantation and at 3, 12 and 60 months posttransplantation, and fractures were recorded. The median intact parathyroid hormone (PTH) level was 334 ng/L (interquartile 151-642) at the time of transplantation and 123 ng/L (interquartile 75-224) at 3 months. Thirty fractures occurred in 22 patients. The receiver operating characteristic (ROC) curve analysis for PTH at 3 months (area under the ROC curve = 0.711, p = 0.002) showed that a good threshold for predicting fractures was 130 ng/L (sensitivity = 81%, specificity = 57%). In a multivariable analysis, independent risk factors for fracture were PTH >130 ng/L at 3 months (adjusted hazard ratio [AHR] = 7.5, 95% CI 2.18-25.50), and pretransplant osteopenia (AHR = 2.7, 95% CI 1.07-7.26). In summary, this study demonstrates for the first time that persistent hyperparathyroidism is an independent risk factor for fractures after kidney transplantation. © Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Bone mineral density; bone turnover markers; fracture; hyperparathyroidism; hypophosphatemia; kidney transplantation

Mesh:

Substances:

Year:  2013        PMID: 24034142     DOI: 10.1111/ajt.12425

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  40 in total

1.  Changes in bone mineral density following long-term simultaneous pancreas-kidney transplantation.

Authors:  Ana Rocha; La Salete Martins; Jorge Malheiro; Jorge Dores; Clara Santos; Castro Henriques
Journal:  J Bone Miner Metab       Date:  2015-04-03       Impact factor: 2.626

Review 2.  Bone Disease after Kidney Transplantation.

Authors:  Antoine Bouquegneau; Syrazah Salam; Pierre Delanaye; Richard Eastell; Arif Khwaja
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-15       Impact factor: 8.237

Review 3.  Biomarkers Predicting Bone Turnover in the Setting of CKD.

Authors:  Pieter Evenepoel; Etienne Cavalier; Patrick C D'Haese
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

Review 4.  Bone Quality in Chronic Kidney Disease: Definitions and Diagnostics.

Authors:  Erin M B McNerny; Thomas L Nickolas
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

5.  The utility of circulating markers to predict bone loss across the CKD spectrum.

Authors:  Thomas L Nickolas
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-19       Impact factor: 8.237

Review 6.  Bone imaging and fracture risk assessment in kidney disease.

Authors:  Sophie A Jamal; Thomas L Nickolas
Journal:  Curr Osteoporos Rep       Date:  2015-06       Impact factor: 5.096

Review 7.  Can one evaluate bone disease in chronic kidney disease without a biopsy?

Authors:  Revekka Babayev; Thomas L Nickolas
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-07       Impact factor: 2.894

Review 8.  Mineral and bone disorder after kidney transplantation.

Authors:  Pahnwat T Taweesedt; Sinee Disthabanchong
Journal:  World J Transplant       Date:  2015-12-24

9.  Changes in Bone Histomorphometry after Kidney Transplantation.

Authors:  Satu Keronen; Leena Martola; Patrik Finne; Inari S Burton; Heikki Kröger; Eero Honkanen
Journal:  Clin J Am Soc Nephrol       Date:  2019-05-14       Impact factor: 8.237

Review 10.  Bone kidney interactions.

Authors:  Thomas L Nickolas; Sophie A Jamal
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.